CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Apr 26 05:33 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.
Apr 26 04:31 ET
CSPC PHARMA: NOTIFICATION LETTER TO NON-REGISTERED HOLDER AND REQUEST FORM
Apr 25 10:25 ET
CSPC PHARMA: NOTIFICATION LETTER TO SHAREHOLDER AND CHANGE REQUEST FORM
Apr 25 10:25 ET
CSPC PHARMA: LETTER TO NEW REGISTERED SHAREHOLDERS AND REPLY FORM
Apr 25 10:24 ET
CSPC PHARMA: PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024 AT 10:00 A.M. (AND AT ANY ADJOURNMENT THEREOF)
Apr 25 10:23 ET
CSPC PHARMA: NOTICE OF ANNUAL GENERAL MEETING
Apr 25 10:22 ET
CSPC PHARMA: PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, MANDATE TO GRANT OPTIONS AND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Apr 25 10:21 ET
CSPC PHARMA: 2023 Environmental, Social and Governance Report
Apr 25 10:20 ET
CSPC PHARMA: 2023 ANNUAL REPORT
Apr 25 10:16 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Apr 24 05:34 ET
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Apr 23 05:52 ET
CSPC PHARMA: INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2024
Apr 22 09:32 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 22 06:17 ET
CSPC PHARMA: GRANT OF SHARE AWARDS PURSUANT TO THE SHARE AWARD SCHEME OF THE COMPANY
Apr 22 05:06 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 19 05:51 ET
CSPC PHARMA: CONTINUING CONNECTED TRANSACTIONS IN RELATION TO MASTER SALES AGREEMENT
Apr 19 04:53 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 18 05:45 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 17 06:22 ET
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 16 05:59 ET
No Data
No Data